हाल में देखा गया
सब क्लियर करें
उच्चतम: लो: रिटर्न:
अधिकतम: निम्नतम: मीडियन:
$43,748 मिलियन
31.13
6.5
--
1.8
22.19 %
--
--
--
7710472
इयर-टू-डेट
|
1 महीना
|
3 महीने
|
1 साल
|
3 साल
|
5 साल
|
10 साल
|
|
---|---|---|---|---|---|---|---|
IQVIA Holdings (IQV)
| 4.88 | 1.27 | 13.76 | 14.62 | -1.81 | 9.67 | 15.75 |
BSE Sensex*
| 15.55 | 3.77 | 7.98 | 23.48 | 12.25 | 17.95 | 11.90 |
एस एंड पी मिड-कैप 400
| 10.44 | 2.01 | 5.16 | 19.66 | 4.68 | 9.41 | 8.00 |
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
---|---|---|---|---|---|---|---|
IQVIA Holdings (IQV)
| 12.93 | -27.38 | 57.47 | 15.96 | 33.00 | 18.55 | 28.73 |
S&P Midcap 400
| 14.45 | -14.48 | 23.21 | 11.81 | 24.05 | -12.43 | 14.45 |
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 |
शेयर
|
पियर मीडियन
|
||
---|---|---|---|
लोडिंग... |
शेयर
|
पियर मीडियन
|
||
---|---|---|---|
लोडिंग... |
क्या कंपनी में सॉल्वेंसी का कोई ख़तरा है?
क्या अकाउंटिंग की किसी गड़बड़ी का अंदेशा है?
कंपनी का पिछले एक साल का प्रदर्शन कैसा रहा?
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments:... Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina. Address: 2400 Ellis Road, Durham, NC, United States, 27703 और पढ़ें
IQVIA Holdings Inc (IQV) की कुल एसेट वैल्यू 30-जून-24 को $33,018 मिलियन थी.
IQVIA Holdings Inc (IQV) का शेयर प्राइस 18-सितंबर-2024 16:28 EDT तक $242.67 (NYSE) है. IQVIA Holdings Inc (IQV) ने पिछले 3 साल में -1.81% फ़ीसदी का रिटर्न दिया है.
IQVIA Holdings Inc (IQV) का मार्किट कैपिटलाइज़ेशन, 18-सितंबर-2024 तक $ 43,748 मिलियन है, VRO क्लासिफ़िकेशन के अनुसार ये एक मिड कैप कंपनी है.
18-सितंबर-2024 को IQVIA Holdings Inc (IQV) का PB रेशियो 6.50 गुना है, जो इसके जैसी कंपनियों की औसत सीमा 3.39 गुना से 92% प्रीमियम पर है.
18-सितंबर-2024 का P/E रेशियो IQVIA Holdings Inc. (IQV).तक 31.13 गुना है.
स्टेप 1. ब्रोकर की मदद से एक डीमैट अकाउंट खोलें. KYC के लिए आपको अपना ईमेल, पैन, बैंक अकाउंट डिटेल, आधार के डिटेल आदि देने होंगे.
स्टेप 2. मोबाइल ऐप या वेबसाइट के ज़रिये ब्रोकर के एप्लिकेशन में साइन-इन करें. अपने ब्रोकर से मिली लॉग-इन आईडी और पासवर्ड का इस्तेमाल करें.
स्टेप 3. अपने बैंक अकाउंट से अपने ब्रोकरेज अकाउंट में मौजूद वॉलेट में फंड्स ट्रांसफ़र करें.
स्टेप 4. IQVIA Holdings Inc (IQV) सर्च करें और आवश्यक संख्या में क्वांटिटी डालें और IQVIA Holdings Inc (IQV) के शेयर ख़रीदने के लिए ख़रीदें पर क्लिक करें.
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina. Address: 2400 Ellis Road, Durham, NC, United States, 27703
श्री आरी बौसबिब IQVIA Holdings Inc (IQV) के CEO और डायरेक्टर हैं, और श्री रोनाल्ड इ. बृएहलमन CFO और सीनियर VP हैं.
IQVIA Holdings Inc (IQV) में कोई प्रमोटर प्लेजिंग नहीं रखता है.
पीयर्स या इसी जैसी कुछ दूसरी कंपनियां
कंपनी | मार्केट कैप($ मिलियन) |
---|---|
3,362
|
|
3,056
|
|
1,540
|
|
1,439
|
IQVIA Holdings Inc. (IQV) | रेशियो |
---|---|
इक्विटी पर रिटर्न(%)
|
22.19
|
ऑपरेटिंग मार्जिन(%)
|
14.42
|
नेट मार्जिन(%)
|
9.36
|
डिविडेंड यील्ड(%)
|
--
|
हां, IQVIA Holdings Inc (IQV) का टैक्स के बाद TTM प्रॉफिट $303 मिलियन था.